会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • ANTI-HUMAN CLCP1 ANTIBODY AND USE THEREOF
    • 抗人CLCP1抗体及其用途
    • US20110293618A1
    • 2011-12-01
    • US13054554
    • 2009-07-16
    • Ken-ichiro OnoTakashi Takahashi
    • Ken-ichiro OnoTakashi Takahashi
    • A61K39/395C12P21/02C12N5/10C12N1/21A61P35/04G01N33/574C07K16/18C07H21/00A61P35/00C12N15/63C12N1/19
    • G01N33/574A61K2039/505C07K16/3023C07K2317/24C07K2317/56C07K2317/565C07K2317/73C07K2317/732C07K2317/77C07K2317/92G01N33/5011
    • The present invention provides novel antibodies that recognize the extracellular domain of a human CLCP1 antigen; nucleic acids encoding the antibodies; vectors carrying the nucleic acids in an expressible manner; transformed cells containing the vectors; methods for producing the antibodies; diagnostic methods for cancer or prognosis of cancer, immunohistological or immunocytological assay methods, and kits for determining the expression level of CLCP1 in cells or tissues, all of which use the antibodies; pharmaceutical compositions comprising the antibodies; agents for treating or preventing CLCP1-expressing cancer; agents for inhibiting growth, migration, invasion, or metastasis of CLCP1-expressing cancer cells; immunostaining agents for staining CLCP1-expressing cancer cells; and agents for treating or preventing CLCP1-expressing tumor. The present invention also provides methods of screening for candidate substances that inhibit cancer cell growth, invasion, migration, or metastasis, or candidate substances having cytotoxicity against cancer cells.
    • 本发明提供识别人CLCP1抗原的细胞外结构域的新型抗体; 编码抗体的核酸; 以可表达的方式携带核​​酸的载体; 含有载体的转化细胞; 生产抗体的方法; 用于癌症或癌症预后的诊断方法,免疫组织化学或免疫细胞学测定方法以及用于测定细胞或组织中所有这些抗体的CLCP1表达水平的试剂盒; 包含抗体的药物组合物; 治疗或预防CLCP1表达癌症的药剂; 用于抑制表达CLCP1的癌细胞的生长,迁移,侵袭或转移的药剂; 用于染色表达CLCP1的癌细胞的免疫染色剂; 和用于治疗或预防表达CLCP1的肿瘤的药剂。 本发明还提供筛选抑制癌细胞生长,侵袭,迁移或转移的候选物质或对癌细胞具有细胞毒性的候选物质的方法。
    • 3. 发明授权
    • Anti-human CLCP1 antibody and use thereof
    • 抗人CLCP1抗体及其用途
    • US08993728B2
    • 2015-03-31
    • US13054554
    • 2009-07-16
    • Ken-ichiro OnoTakashi Takahashi
    • Ken-ichiro OnoTakashi Takahashi
    • A61K39/395G01N33/574C07K16/30G01N33/50A61K39/00
    • G01N33/574A61K2039/505C07K16/3023C07K2317/24C07K2317/56C07K2317/565C07K2317/73C07K2317/732C07K2317/77C07K2317/92G01N33/5011
    • The present invention provides novel antibodies that recognize the extracellular domain of a human CLCP1 antigen; nucleic acids encoding the antibodies; vectors carrying the nucleic acids in an expressible manner; transformed cells containing the vectors; methods for producing the antibodies; diagnostic methods for cancer or prognosis of cancer, immunohistological or immunocytological assay methods, and kits for determining the expression level of CLCP1 in cells or tissues, all of which use the antibodies; pharmaceutical compositions comprising the antibodies; agents for treating or preventing CLCP1-expressing cancer; agents for inhibiting growth, migration, invasion, or metastasis of CLCP1-expressing cancer cells; immunostaining agents for staining CLCP1-expressing cancer cells; and agents for treating or preventing CLCP1-expressing tumor. The present invention also provides methods of screening for candidate substances that inhibit cancer cell growth, invasion, migration, or metastasis, or candidate substances having cytotoxicity against cancer cells.
    • 本发明提供识别人CLCP1抗原的细胞外结构域的新型抗体; 编码抗体的核酸; 以可表达的方式携带核​​酸的载体; 含有载体的转化细胞; 生产抗体的方法; 用于癌症或癌症预后的诊断方法,免疫组织化学或免疫细胞学测定方法以及用于测定细胞或组织中所有这些抗体的CLCP1表达水平的试剂盒; 包含抗体的药物组合物; 治疗或预防CLCP1表达癌症的药剂; 用于抑制表达CLCP1的癌细胞的生长,迁移,侵袭或转移的药剂; 用于染色表达CLCP1的癌细胞的免疫染色剂; 和用于治疗或预防表达CLCP1的肿瘤的药剂。 本发明还提供筛选抑制癌细胞生长,侵袭,迁移或转移的候选物质或对癌细胞具有细胞毒性的候选物质的方法。
    • 8. 发明授权
    • Transferring web contents
    • 传送网页内容
    • US07610355B2
    • 2009-10-27
    • US11832681
    • 2007-08-02
    • Shigeo AzumaTakashi TakahashiToshifumi Takahashi
    • Shigeo AzumaTakashi TakahashiToshifumi Takahashi
    • G06F15/16
    • H04L67/06H04L67/02
    • To transfer web contents to a web server from a computer through a network, a plurality of files composing the web contents are stored in the computer. A processor of the computer then detects files to be transferred from the plurality of files to create a transfer file list table. A transfer priority of the files to be transferred is determined by the processor on the basis of reference relation data of the files to be transferred which are designated in the transfer file list table and file format data of the plurality of files to create a transfer priority list table for the files to be transferred. The files to be transferred are transferred to the web server from a communication controller of the computer through the network by the processor in order of the transfer priority set in the transfer priority list table.
    • 为了通过网络从计算机将web内容传送到web服务器,组成Web内容的多个文件被存储在计算机中。 然后,计算机的处理器检测要从多个文件传送的文件以创建传送文件列表表。 要传送的文件的传送优先级由处理器根据在传送文件列表表中指定的要传送的文件的参考关系数据和多个文件的文件格式数据来确定,以创建传送优先级 列表要传输的文件。 要传送的文件按照传输优先级列表表中设置的传送优先级的顺序,由处理器从计算机的通信控制器通过网络传输到Web服务器。